Memantine






481 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 887505 Interaction of bradykinin with dopaminergic receptors in the CNS. Pol J Pharmacol Pharm 1977 May-Jun 1
2 1426020 gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 1992 Jul 1 3
3 1475066 Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX. Neurotoxicology 1992 Fall 1
4 1620355 Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 1992 Jul 3
5 1707644 Susceptibility of primary human glial fibrillary acidic protein-positive brain cells to human immunodeficiency virus infection in vitro: anti-HIV activity of memantine. AIDS Res Hum Retroviruses 1991 Jan 2
6 1733053 Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol Appl Pharmacol 1992 Jan 1
7 2226632 Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 1990 Aug 21 1
8 2241428 Methyl parathion acute toxicity: prophylaxis and therapy with memantine and atropine. Arch Int Pharmacodyn Ther 1990 May-Jun 2
9 2548883 Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line. Eur J Pharmacol 1989 May 11 4
10 2778846 Prevention and antagonism of acute carbofuran intoxication by memantine and atropine. J Toxicol Environ Health 1989 2
11 2897441 Interaction of memantine with cholecystokinin receptors in mouse brain. J Pharm Pharmacol 1988 Feb 4
12 7874313 HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur J Neurosci 1994 Nov 1 1
13 7893259 Effects of memantine on synaptic transmission in the hippocampus in vitro. Arzneimittelforschung 1995 Jan 1
14 8207837 Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994 Jul 1
15 8646415 Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol 1996 Feb 1
16 8724036 Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 1996 May 1
17 8731170 Memantine reduces functional and morphological consequences induced by global ischemia in rats. Neurosci Lett 1996 Apr 12 1
18 8822372 Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996 Jan 15 5
19 8822791 Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention. Prog Mol Subcell Biol 1996 3
20 8886398 Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol 1996 Sep 4
21 8973791 Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain. Brain Res 1996 Nov 18 4
22 9296567 Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70. Brain Res 1997 Jul 25 1
23 9593857 Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat. Brain Res 1998 May 4 1
24 9687576 Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 1998 Aug 2
25 9871440 Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids 1998 1
26 10051128 NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br J Pharmacol 1999 Jan 1
27 10217297 Pathways of cadmium influx in mammalian neurons. J Neurochem 1999 May 1
28 10391443 Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes. Neuroscience 1999 2
29 10471078 Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices. Neuropharmacology 1999 Sep 1
30 10665489 Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 2000 Feb 3
31 10737358 No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci 2000 Feb 11 2
32 10885864 Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry 1999 Feb 1
33 11060751 Evaluation of memantine for neuroprotection in dementia. Expert Opin Investig Drugs 2000 Jun 1
34 11069578 Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro. Eur J Neurosci 2000 Nov 1
35 11169168 Uncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex. Pharmacol Toxicol 2001 Feb 3
36 11282259 Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 2001 May 1
37 11326240 The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine model. J Thorac Cardiovasc Surg 2001 May 1
38 11369029 The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 2001 May 1
39 11591126 The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 2001 Sep 11
40 11823786 Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 2002 Feb 14 2
41 11854433 Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. Mol Pharmacol 2002 Mar 2
42 12409683 A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002 Nov 1
43 12468047 Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res 2002 Dec 20 1
44 12750440 Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003 Aug 2
45 12875722 The regulatory effect of memantine on expression and synthesis of heat shock protein 70 gene in neonatal rat models with cerebral hypoxic ischemia. Chin Med J (Engl) 2003 Apr 4
46 14730114 Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol J Pharmacol 2003 Nov-Dec 4
47 14741410 Adenosine A2A receptor mRNA expression is increased in rat striatum and nucleus accumbens after memantine administration. Brain Res Mol Brain Res 2004 Jan 5 1
48 14970830 Identification of genes regulated by memantine and MK-801 in adult rat brain by cDNA microarray analysis. Neuropsychopharmacology 2004 Jun 1
49 15033007 [Protective effect of memantine on N-methyl-D-aspartate receptor in dichlorvos-poisoned rat brain]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2004 Feb 1
50 15090047 Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine. Eur J Neurosci 2004 Apr 2